You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

DEPAKENE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Depakene, and when can generic versions of Depakene launch?

Depakene is a drug marketed by Abbvie and is included in two NDAs.

The generic ingredient in DEPAKENE is valproic acid. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the valproic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Depakene

A generic version of DEPAKENE was approved as valproic acid by CATALENT on October 29th, 1991.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DEPAKENE?
  • What are the global sales for DEPAKENE?
  • What is Average Wholesale Price for DEPAKENE?
Drug patent expirations by year for DEPAKENE
Drug Prices for DEPAKENE

See drug prices for DEPAKENE

Recent Clinical Trials for DEPAKENE

Identify potential brand extensions & 505(b)(2) entrants

M.D. Anderson Cancer CenterPhase 2/Phase 3
Cancer Prevention Research Institute of TexasPhase 2/Phase 3
Kimberly S JonesPhase 2

See all DEPAKENE clinical trials

US Patents and Regulatory Information for DEPAKENE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie DEPAKENE valproic acid CAPSULE;ORAL 018081-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie DEPAKENE valproic acid SYRUP;ORAL 018082-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.